Ravi Salgia, MD, PhD, is chair and professor in the department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center.
Choosing Therapy for NSCLC to SCLC Transformation in EGFR+ Disease
Ravi Salgia, MD, PhD, discusses how to address and treat transformation from non–small cell lung cancer to small cell lung cancer.
Key Signs of SCLC Transformation in Patients With EGFR+ NSCLC
Ravi Salgia, MD, PhD, discusses the ways in which oncologists can watch out for non-small cell lung cancer that transforms to small-cell lung cancer.
Examining Transformation of NSCLC to SCLC in EGFR+ Disease
Ravi Salgia, MD, PhD, discusses the results from a study of LB-100 combined with chemotherapy or immunotherapy to address transformation from non-small cell lung cancer to small cell lung cancer.